Skip to main content
JETEMA Co.,Ltd. logo

JETEMA Co.,Ltd. — Investor Relations & Filings

Ticker · 216080 ISIN · KR7216080002 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2026-03-18 Audit Report / Informat…
Country KR South Korea
Listing KO 216080

About JETEMA Co.,Ltd.

http://www.jetema.com/

JETEMA Co., Ltd. is a research-driven biopharmaceutical company specializing in the development and manufacturing of innovative medicines and medical devices for the aesthetic medicine market. The company's core product portfolio includes botulinum toxins, hyaluronic acid-based dermal fillers, and lifting threads. With a strong focus on research and development, JETEMA aims to provide advanced solutions for anti-aging and aesthetic enhancement. The company's name is derived from the Latin word 'Zetéma', meaning 'research', reflecting its commitment to scientific innovation in creating products for a healthy and beautiful life.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korea Exchange (KRX). It contains key financial data, audit opinions, and financial statements for the fiscal year. While it provides financial summaries, it is a standard regulatory disclosure form used in the Korean market to announce the completion and submission of the audit report, rather than the full, multi-page annual report document itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2025
2026-03-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (often referred to as an 'Insider Trading Report' or 'Director's Dealing' report) where company executives or major shareholders disclose changes in their personal shareholdings. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2026-03-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Park Jong-woo) of Jetema Co., Ltd. This type of filing, which details personal share transactions (insider trading) by company directors or executives, is classified as 'Director's Dealing' (DIRS) in the provided schema.
2026-03-16 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Annual General Meeting' (주주총회소집공고) for the 17th Annual General Meeting of Jetema Co., Ltd. It includes the meeting date, location, agenda items (financial statement approval, director appointments, etc.), and information regarding electronic voting. This document is a standard proxy solicitation and meeting notice provided to shareholders to inform them of the upcoming meeting and request their participation/votes. According to the provided definitions, this fits the 'Proxy Solicitation & Information Statement' (PSI) category.
2026-03-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details specific share transactions (buy/sell) by an individual named Park Jae-seong, who is identified as an executive (standing auditor) of the company Jetema. This is a standard regulatory filing for insider trading/director dealings in the Korean market, which corresponds to the 'Director's Dealing' category.
2026-03-11 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (Proxy Solicitation & Information Statement). It contains details regarding the upcoming Annual General Meeting (AGM), including the agenda, voting procedures, and financial statements (both consolidated and separate) for the fiscal year 2025. Since the primary purpose of this document is to solicit proxies from shareholders for the AGM, it falls under the 'Proxy Solicitation & Information Statement' category.
2026-03-11 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.